Darwin Completes Its First Exit


Darwin Private Equity has today completed the sale of Maxinutrition to GlaxoSmithKline plc for £162 million, having obtained approval from the Office of Fair Trading. Maxinutrition, the parent company of Maximuscle, Maxifuel and Maxitone, is Europe’s leading sports nutrition company.

The sale of Maxinutrition is Darwin’s first exit from its inaugural Fund.

Back to latest news